Klemann, C., Camacho-Ordonez, N., Yang, L., Eskandarian, Z., Rojas Restrepo, J. L., Frede, N., Bulashevska, A., Heeg, M., Alddafari, M. S., Premm, J., Seidl, M., Ammann, S., Sherkat, R., Radhakrishnan, N., Warnatz, K., Unger, S., Kobbe, R., Hüfner, A.-D., Leahy, T. R., Ip, W., Burns, S. O., Fliegauf, M., & Grimbacher, B. (ca. 2019). Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2 [Cd]. Universität. https://doi.org/10.3389/fimmu.2019.00297
The Open University - HarvardKlemann, C., Camacho-Ordonez, N., Yang, L., Eskandarian, Z., Rojas Restrepo, J. L., Frede, N., Bulashevska, A., Heeg, M., Alddafari, M. S., Premm, J., Seidl, M., Ammann, S., Sherkat, R., Radhakrishnan, N., Warnatz, K., Unger, S., Kobbe, R., Hüfner, A.-D., Leahy, T. R., Ip, W., Burns, S. O., Fliegauf, M. und Grimbacher, B. (2019) Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2, Freiburg, Universität [Online]. DOI: 10.3389/fimmu.2019.00297.
IEEE[1]C. Klemann, Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Freiburg: Universität, 2019. doi: 10.3389/fimmu.2019.00297.
Vancouver1. Klemann C, Camacho-Ordonez N, Yang L, Eskandarian Z, Rojas Restrepo JL, Frede N, Bulashevska A, Heeg M, Alddafari MS, Premm J, Seidl M, Ammann S, Sherkat R, Radhakrishnan N, Warnatz K, Unger S, Kobbe R, Hüfner A-D, Leahy TR, Ip W, Burns SO, Fliegauf M, Grimbacher B. Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Freiburg: Universität; 2019. Online-Ressource.
Betriebswirtschaftliche Forschung und Praxis (Deutsch)Klemann, C./Camacho-Ordonez, N./Yang, L./Eskandarian, Z./Rojas Restrepo, J. L./Frede, N./Bulashevska, A./Heeg, M./Alddafari, M. S./Premm, J./Seidl, M./Ammann, S./Sherkat, R./Radhakrishnan, N./Warnatz, K./Unger, S./Kobbe, R./Hüfner, A.-D./Leahy, T. R./Ip, W./Burns, S. O./Fliegauf, M./Grimbacher, B. (2019), Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2, Freiburg.